12.01.2017
- French drugmaker Ipsen has signed a definitive agreement to buy the global oncology assets of US-based Merrimack Pharmaceuticals in a deal worth potentially more than $1 billion...
20.12.2016
- Proteros Biostructures has entered into a second research agreement with Merck Sharp & Dohme (known as MSD outside the US and Canada). The new collaboration is aimed at developing...
08.11.2016
- Cancer Research UK is aligning with the Wellcome Trust and investment groups Syncona and BACIT to create a new company with assets of up to £1 billion that will invest in life...
25.10.2016
- Major drugmakers Merck KGaA of Germany and Pfizer of the US are collaborating with Debiopharm International, a drug developer based in Lausanne, Switzerland to study the potential...
06.07.2016
- European regulators have approved the use of Amgen’s cancer drug Kyprolis in combination with just dexamethasone to treat certain adults with multiple myeloma, an incurable blood...
29.06.2016
- The US federal government’s National Institutes of Health (NIH) has declined a petition from a public interest group to lower the price of a drug for advanced prostate cancer...
06.06.2016
- The European Commission has granted approval for Novartis’ Afinitor (everolimus) for treating unresectable or metastatic, well-differentiated non-functional neuroendocrine tumors...
04.05.2016
- An R&D collaboration between Dublin, Ireland-based Nexvet Biopharma, a veterinary biologics developer, and Japanese animal health company Zenoaqa claims to have found fully...
